ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases
- 1 November 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 12 (22) , 5753-5766
- https://doi.org/10.1016/j.bmc.2004.08.043
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Src Family Kinases: Potential Targets for the Treatment of Human Cancer and LeukemiaCurrent Pharmaceutical Design, 2003
- Imatinib alone and in combination for chronic myeloid leukemiaSeminars in Hematology, 2003
- Epidermal growth factor receptor tyrosine kinase inhibitorsCurrent Opinion in Pharmacology, 2002
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001
- FAK integrates growth-factor and integrin signals to promote cell migrationNature Cell Biology, 2000
- Neurotrophins in Cell Survival/Death DecisionsPublished by Springer Nature ,1999
- c-Src, Receptor Tyrosine Kinases, and Human CancerAdvances in Cancer Research, 1999
- Signal transduction by fibroblast growth factor receptorsFrontiers in Bioscience-Landmark, 1999
- Multiple functions of the EGF receptor in Drosophila eye developmentCurrent Biology, 1998